272 related articles for article (PubMed ID: 19793165)
1. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell invasion by modulating transforming growth factor-beta/Smad in HepG2 cell.
Liu X; Yang Y; Zhang X; Xu S; He S; Huang W; Roberts MS
J Gastroenterol Hepatol; 2010 Feb; 25(2):420-6. PubMed ID: 19793165
[TBL] [Abstract][Full Text] [Related]
2. Compound Astragalus and Salvia miltiorrhiza Extract exerts anti-fibrosis by mediating TGF-beta/Smad signaling in myofibroblasts.
Yang Y; Yang S; Chen M; Zhang X; Zou Y; Zhang X
J Ethnopharmacol; 2008 Jul; 118(2):264-70. PubMed ID: 18502066
[TBL] [Abstract][Full Text] [Related]
3. Compound Astragalus and Salvia miltiorrhiza extract inhibits cell proliferation, invasion and collagen synthesis in keloid fibroblasts by mediating transforming growth factor-β / Smad pathway.
He S; Yang Y; Liu X; Huang W; Zhang X; Yang S; Zhang X
Br J Dermatol; 2012 Mar; 166(3):564-74. PubMed ID: 21967214
[TBL] [Abstract][Full Text] [Related]
4. Compound Astragalus and Salvia miltiorrhiza extracts suppress hepatocarcinogenesis by modulating transforming growth factor-β/Smad signaling.
Hu X; Rui W; Wu C; He S; Jiang J; Zhang X; Yang Y
J Gastroenterol Hepatol; 2014 Jun; 29(6):1284-91. PubMed ID: 24329763
[TBL] [Abstract][Full Text] [Related]
5. Compound Astragalus and Salvia miltiorrhiza extracts modulate MAPK-regulated TGF-β/Smad signaling in hepatocellular carcinoma by multi-target mechanism.
Boye A; Wu C; Jiang Y; Wang J; Wu J; Yang X; Yang Y
J Ethnopharmacol; 2015 Jul; 169():219-28. PubMed ID: 25934513
[TBL] [Abstract][Full Text] [Related]
6. Compound Astragalus and Salvia miltiorrhiza extract inhibits hepatocellular carcinoma progression via miR-145/miR-21 mediated Smad3 phosphorylation.
Wu C; Chen W; Fang M; Boye A; Tao X; Xu Y; Hou S; Yang Y
J Ethnopharmacol; 2019 Mar; 231():98-112. PubMed ID: 30412748
[TBL] [Abstract][Full Text] [Related]
7. Compound Astragalus and Salvia miltiorrhiza extract suppresses hepatocellular carcinoma progression by inhibiting fibrosis and PAI-1 mRNA transcription.
Rui W; Xie L; Liu X; He S; Wu C; Zhang X; Zhang L; Yang Y
J Ethnopharmacol; 2014; 151(1):198-209. PubMed ID: 24247078
[TBL] [Abstract][Full Text] [Related]
8. Regulatory mechanisms for transforming growth factor beta as an autocrine inhibitor in human hepatocellular carcinoma: implications for roles of smads in its growth.
Matsuzaki K; Date M; Furukawa F; Tahashi Y; Matsushita M; Sugano Y; Yamashiki N; Nakagawa T; Seki T; Nishizawa M; Fujisawa J; Inoue K
Hepatology; 2000 Aug; 32(2):218-27. PubMed ID: 10915727
[TBL] [Abstract][Full Text] [Related]
9. Distortion of autocrine transforming growth factor beta signal accelerates malignant potential by enhancing cell growth as well as PAI-1 and VEGF production in human hepatocellular carcinoma cells.
Sugano Y; Matsuzaki K; Tahashi Y; Furukawa F; Mori S; Yamagata H; Yoshida K; Matsushita M; Nishizawa M; Fujisawa J; Inoue K
Oncogene; 2003 Apr; 22(15):2309-21. PubMed ID: 12700666
[TBL] [Abstract][Full Text] [Related]
10. Astragalus and Paeoniae Radix Rubra extract (APE) inhibits hepatic stellate cell activation by modulating transforming growth factor-β/Smad pathway.
Huang W; Li L; Tian X; Yan J; Yang X; Wang X; Liao G; Qiu G
Mol Med Rep; 2015 Apr; 11(4):2569-77. PubMed ID: 25435153
[TBL] [Abstract][Full Text] [Related]
11. [Epigallocatechin gallate induces apoptosis in human hepatocellular carcinoma HepG2 cells via TGF/Smad signaling pathway].
Tong JL; Nie F; Ran ZH; Pan CQ; Xu XT; Zhu MM; Xiao SD
Zhonghua Zhong Liu Za Zhi; 2009 Sep; 31(9):646-50. PubMed ID: 20021857
[TBL] [Abstract][Full Text] [Related]
12. Curcumin inhibits transforming growth factor-beta activity via inhibition of Smad signaling in HK-2 cells.
Hu Y; Liang H; Du Y; Zhu Y; Wang X
Am J Nephrol; 2010; 31(4):332-41. PubMed ID: 20160437
[TBL] [Abstract][Full Text] [Related]
13. Modulators of induction of plasminogen activator inhibitor type-1 in HepG2 cells by transforming growth factor-β.
Nakayama N; Nakamura T; Okada H; Iwaki S; Sobel BE; Fujii S
Coron Artery Dis; 2011 Nov; 22(7):468-78. PubMed ID: 21968503
[TBL] [Abstract][Full Text] [Related]
14. Interferon-gamma suppresses transforming growth factor-beta-induced invasion of gastric carcinoma cells through cross-talk of Smad pathway in a three-dimensional culture model.
Kuga H; Morisaki T; Nakamura K; Onishi H; Noshiro H; Uchiyama A; Tanaka M; Katano M
Oncogene; 2003 Oct; 22(49):7838-47. PubMed ID: 14586410
[TBL] [Abstract][Full Text] [Related]
15. MAPK inhibitors differently modulate TGF-β/Smad signaling in HepG2 cells.
Boye A; Kan H; Wu C; Jiang Y; Yang X; He S; Yang Y
Tumour Biol; 2015 May; 36(5):3643-51. PubMed ID: 25560488
[TBL] [Abstract][Full Text] [Related]
16. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
[TBL] [Abstract][Full Text] [Related]
17. TGF-beta activated Smad signalling leads to a Smad3-mediated down-regulation of DSPP in an odontoblast cell line.
He WX; Niu ZY; Zhao SL; Jin WL; Gao J; Smith AJ
Arch Oral Biol; 2004 Nov; 49(11):911-8. PubMed ID: 15353247
[TBL] [Abstract][Full Text] [Related]
18. Smad protein mediated transforming growth factor beta1 induction of apoptosis in the MDPC-23 odontoblast-like cell line.
He WX; Niu ZY; Zhao SL; Smith AJ
Arch Oral Biol; 2005 Nov; 50(11):929-36. PubMed ID: 16183370
[TBL] [Abstract][Full Text] [Related]
19. Sonic hedgehog signaling promotes motility and invasiveness of gastric cancer cells through TGF-beta-mediated activation of the ALK5-Smad 3 pathway.
Yoo YA; Kang MH; Kim JS; Oh SC
Carcinogenesis; 2008 Mar; 29(3):480-90. PubMed ID: 18174246
[TBL] [Abstract][Full Text] [Related]
20. Radiation and transforming growth factor-beta cooperate in transcriptional activation of the profibrotic plasminogen activator inhibitor-1 gene.
Hageman J; Eggen BJ; Rozema T; Damman K; Kampinga HH; Coppes RP
Clin Cancer Res; 2005 Aug; 11(16):5956-64. PubMed ID: 16115939
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]